FED降息预测竟暗含危机?华尔街大佬:预示衰退即将到来
- 0001年1月1日
注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
DBV Technologies SA是一家法国的临床阶段生物制药公司,致力于通过开发名为Vaskin的技术平台来改变免疫疗法的业务。该公司的治疗方法基于表皮免疫疗法,即EPIT,它是使用Viaskin通过完整皮肤向免疫系统提供生物活性化合物的专有方法。该公司致力于治疗患有严重食物过敏的患者,包括婴儿和儿童,对这些患者来说,安全性至关重要,因为将不良过敏原引入血液中会导致严重或危及生命的过敏反应,例如过敏性休克。该公司用于过敏治疗的产品包括Viaskin花生、Viaskin牛奶和Viaskin鸡蛋。该公司在美国运营着一家子公司DBV Technologies Inc。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Pierre-Henri Benhamou | 66 | 2002 | Co-Founder & Member of Scientific Advisory Board |
Gideon Lack | - | - | Member of the Scientific Advisory Board |
Jonathan M. Spergel | - | - | Member of the Scientific Advisory Board |
Michael Rosenblum | - | 2019 | Member of Scientific Advisory Board |
Christophe Dupont | - | - | Member of Advisory Board |
Ravi Madduri Rao | 55 | 2021 | Independent Director |
Emma Guttman-Yassky | - | 2019 | Member of Scientific Advisory Board |
Jim Krueger | - | 2019 | Member of Scientific Advisory Board |
Miriam Merad | - | 2019 | Member of Scientific Advisory Board |
Jean-François Nicolas | - | 2019 | Member of Scientific Advisory Board |
Adora Ndu | 41 | 2021 | Independent Director |
Betty A. Diamond | - | 2021 | Member of Scientific Advisory Board |
Daniele Guyot-Caparros | 64 | 2022 | Independent Director |
Michel de Rosen | 72 | 2018 | Independent Chairman of the Board |
Hugh A. Sampson | 74 | 2015 | Scientific Adviser to the CEO & Chairman of Scientific Advisory Board |
Michael J. Goller | 48 | 2015 | Director |
Daniel Tassé | 63 | 2018 | CEO & Director |
Mailys Ferrere | 61 | 2012 | Director |
Paul-Henri Lambert | 84 | - | Member of the Scientific Advisory Board |
Daniel B. Soland | 67 | 2015 | Independent Director |
Timothy E. Morris | 62 | 2021 | Independent Director |
Julie O'Neill | 57 | 2017 | Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核